Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 214 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Liakopoulos, Vassilios  [Clear All Filters]
Journal Article
Karioti, A., Hatzoglou C., Zarogiannis S., Deligiorgi T., Kourti P., Giannopoulou M., et al. (2009).  Spironolactone increases permeability of visceral sheep peritoneum.. Adv Perit Dial. 25, 16-9.
Nikitidou, O., Daskalopoulou E., Papagianni A., Liakopoulos V., Michalaki A., Christidou F., et al. (2018).  Sleep apnea syndrome, inflammation and oxidative stress in hemodialysis patients.. Hemodial Int. 22(2), 209-216.
Spoto, B., Ntounousi E., Testa A., Liakopoulos V., D'Arrigo G., Tripepi G., et al. (2018).  The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study.. J Hypertens. 36(8), 1705-1711.
Zarogiannis, S. G., Liakopoulos V., & Schmitt C. P. (2017).  Single-Nephron Glomerular Filtration Rate in Healthy Adults.. N Engl J Med. 377(12), 1203.
Arampatzis, S., Giannakoulas N., Liakopoulos V., Eleftheriadis T., Kourti P., Karasavvidou F., et al. (2011).  Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.. BMC Nephrol. 12, 33.
Georgianos, P. I., Vaios V., Divani M., & Liakopoulos V. (2023).  Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?. Expert Opin Pharmacother.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
Eleftheriadis, T., Yiannaki E., Liakopoulos V., Antoniadi G., Pissas G., Galaktidou G., et al. (2013).  Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients.. Int Urol Nephrol. 45(6), 1671-7.
Eleftheriadis, T., Pissas G., Antoniadi G., Filippidis G., Golfinopoulos S., Spanoulis A., et al. (2014).  Serum copper and ferroportin in monocytes of hemodialysis patients are both decreased but unassociated.. Int Urol Nephrol. 46(9), 1825-31.
Liakopoulos, V., Eleftheriadis T., & Mertens P. R. (2018).  Screening for renal cell carcinoma in dialysis patients.. Kidney Int. 94(6), 1238.
Kocic, G., Hadzi-Djokic J., Colic M., Veljkovic A., Tomovic K., Roumeliotis S., et al. (2022).  The Role of Nucleases Cleaving TLR3, TLR7/8 and TLR9 Ligands, Dicer RNase and miRNA/piRNA Proteins in Functional Adaptation to the Immune Escape and Xenophagy of Prostate Cancer Tissue.. Int J Mol Sci. 24(1), 
Eleftheriadis, T., Liakopoulos V., Antoniadi G., Kartsios C., & Stefanidis I. (2009).  The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.. Semin Dial. 22(1), 70-7.
Li, P. Kam- Tao, Garcia-Garcia G., Lui S-F., Andreoli S., Fung W. Wing- Shing, Hradsky A., et al. (2020).  Reprint of: Kidney health for everyone everywhere-from prevention to detection and equitable access to care.. Nephrol Ther. 16(4), 211-216.
Eleftheriadis, T., Pissas G., Filippidis G., Liakopoulos V., & Stefanidis I. (2021).  Reoxygenation induces reactive oxygen species production and ferroptosis in renal tubular epithelial cells by activating aryl hydrocarbon receptor.. Mol Med Rep. 23(1), 
Musso, C., Liakopoulos V., Pangre N., DiTrolio J., Jauregui R., De Miguel R., et al. (2009).  Renal physiology in elderly persons with severe immobility syndrome.. Int Urol Nephrol. 41(2), 437-41.
Eleftheriadis, T., Antoniadi G., Pissas G., Liakopoulos V., & Stefanidis I. (2013).  The renal endothelium in diabetic nephropathy.. Ren Fail. 35(4), 592-9.
Schiefer, J., Chatzikyrkou C., Mertens P. R., & Liakopoulos V. (2019).  Remission of nephrotic syndrome after resolution of renal artery stenosis in a patient with a single functional kidney.. Clin Nephrol. 91(4), 265-267.
Roumeliotis, S., Liakopoulos V., Veljkovic A., & Dounousi E. (2023).  Redox Systems Biology in Chronic Kidney Disease.. Oxid Med Cell Longev. 2023, 9864037.
Eleftheriadis, T., Rountas C., Vlassis S., Karagiorgas G., Pissas G., Liakopoulos V., et al. (2017).  Quiz: Nine Years of Persistent, Disabling Foot Pain in a Kidney Transplant Recipient.. Am J Kidney Dis. 70(2), A13-A15.
Giannaki, C. D., Sakkas G. K., Hadjigeorgiou G. M., Liakopoulos V., Anifandis G., Karatzaferi C., et al. (2010).  Quality of life score is primarily affected by the mental rather than the physical component in patients with restless legs syndrome.. Mov Disord. 25(1), 135-6; author reply 136-7.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P. E., & Liakopoulos V. (2020).  Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence.. Curr Vasc Pharmacol.
Eleftheriadis, T., Pissas G., Antoniadi G., Liakopoulos V., & Stefanidis I. (2016).  Proteasome or immunoproteasome inhibitors cause apoptosis in human renal tubular epithelial cells under normoxic and hypoxic conditions.. Int Urol Nephrol. 48(6), 907-15.
Tsiagka, D., Georgianos P. I., Pikilidou M. I., Vaios V., Roumeliotis S., Syrganis C., et al. (2022).  Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis.. Int Urol Nephrol. 54(9), 2327-2334.
Vareta, G., Georgianos P. I., Vaios V., Sgouropoulou V., Georgianou E. I., Leivaditis K., et al. (2022).  Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.. Am J Hypertens. 35(11), 918-922.
Tsikliras, N., Georgianos P. I., Vaios V., Minasidis E., Anagnostara A., Chatzidimitriou C., et al. (2020).  Prevalence and control of hypertension among patients on haemodialysis.. Eur J Clin Invest. 50(10), e13292.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.